Actinium-225 PNT6555

N/A

Report date: 2025/12/02 14:07:02

NME

Base Information

Drug NameActinium-225 PNT6555

Drug Alias Name225Ac-PNT-6555Actinium-225 PNT6555225Ac-PNT-6555

ClassificationRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Nuclides > Actinium > 225AcRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionFibroblast activation protein alpha inhibitors

TargetsProlyl endopeptidase FAP

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesPoint Biopharma Inc

China Registration ClassN/A

Develop Information

Active CompaniesPoint Biopharma Inc

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A